- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05020223
Comparison of Sucess of Pulpotomy, Direct Pulp Capping and Indirect Pulp Capping Modalities Using MTA in Primary Teeth
August 18, 2021 updated by: Mahmoud Ahmed Mahmoud, Minia University
Comparison of Sucess of Pulpotomy, Direct Pulp Capping and Indirect Pulp Capping Modalities Using MTA in Primary Teeth (2 Years Follow up)
450 healthy children with primary teeth of deep carious lesions without signs or symptomes of irreverisible pulp damage was selected randompy divoded into 3 groups each of 150 children that inder go vital pulp therapy through pulpotomy,direct pulp capping or indirect pulp capping using MTA as capping material for each modality then followed up for 2 years or more
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
450
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mahmoud A Mahmoud
- Phone Number: 01009578837
- Email: Mam.dent@gmail.com
Study Locations
-
-
-
Minya, Egypt, 61111
- Recruiting
- Minia University
-
Contact:
- Ahmad Elheeny, PhD
- Phone Number: 00201005560337
- Email: ahmed.elheny@yahoo.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 years to 10 years (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy children
- Aged from 3 to 10 years old
- Deep cariuos primary tooth
Exclusion Criteria:
- Primary teeth with any signs or syptoms of irreversible pulpitis
- Primary teeth of any signs or symptomes of vitality loss
- Primary teeth near to exfoliation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: MTA pulpotomy
Usuing MTA as capping material for cervical pulpotomy as a treatment option for deep carious primary teeth with signs and symptoms of reversible pulpitis in presence of pulp exposure
|
Vital pulp therapy different modalities for management of deep carious lesion in primary teeth
|
|
EXPERIMENTAL: MTA direct pulp capping
Using MTA as capping material in case of trearment of deep carious primary teeth with signs and symptoms of reversible pulpitis with presence of pulp exposure
|
Vital pulp therapy different modalities for management of deep carious lesion in primary teeth
|
|
EXPERIMENTAL: MTA indirect pulp capping
Using MTA as indirect capping material for treatment of deep carious primary teeth with signs and symptoms of reversible pulpitis
|
Vital pulp therapy different modalities for management of deep carious lesion in primary teeth
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tenderness
Time Frame: 2 years
|
Precence or abscence
|
2 years
|
|
Abcess
Time Frame: 2 years
|
Precence or abscence
|
2 years
|
|
Fistula
Time Frame: 2 years
|
Precence or abscence
|
2 years
|
|
lamina dura
Time Frame: 2 years
|
Intact or distorted
|
2 years
|
|
Periapical radiographic radiolucency
Time Frame: 2 years
|
Precence or abcencs
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
August 1, 2020
Primary Completion (ANTICIPATED)
August 1, 2023
Study Completion (ANTICIPATED)
September 1, 2023
Study Registration Dates
First Submitted
August 15, 2021
First Submitted That Met QC Criteria
August 18, 2021
First Posted (ACTUAL)
August 25, 2021
Study Record Updates
Last Update Posted (ACTUAL)
August 25, 2021
Last Update Submitted That Met QC Criteria
August 18, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- 601
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Deep Caries
-
Hacettepe UniversityRecruitingDeep Caries | Dentin CariesTurkey
-
Cairo UniversityCompleted
-
Cairo UniversityCompleted
-
Cairo UniversityCompleted
-
Cairo UniversityCompleted
-
Cairo UniversityRecruiting
-
Cairo UniversityNot yet recruiting
-
Universidad Rey Juan CarlosRecruiting
Clinical Trials on Vital pulp therapy
-
Ain Shams UniversityRecruiting
-
British University In EgyptRecruitingPulpitis - IrreversibleEgypt
-
Future University in EgyptRecruitingIrreversible PulpitisEgypt
-
Minia UniversityNot yet recruiting
-
Postgraduate Institute of Dental Sciences RohtakCompletedReversible Pulpitis
-
Ain Shams UniversityActive, not recruitingSymptomatic Irreversible PulpitisEgypt
-
Cairo UniversityNot yet recruitingPulp Disease, Dental | Knowledge
-
Al-Azhar UniversityActive, not recruitingVital Pulp Therapy in Young Permanent ToothEgypt
-
Future University in EgyptRecruiting
-
Mansoura UniversityCompletedIrreversible Pulpitis | Reversible PulpitisEgypt